These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 7828850)

  • 1. Disruption of retinoblastoma protein function by coexpression of its C pocket fragment.
    Welch PJ; Wang JY
    Genes Dev; 1995 Jan; 9(1):31-46. PubMed ID: 7828850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth suppression by an E2F-binding-defective retinoblastoma protein (RB): contribution from the RB C pocket.
    Whitaker LL; Su H; Baskaran R; Knudsen ES; Wang JY
    Mol Cell Biol; 1998 Jul; 18(7):4032-42. PubMed ID: 9632788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formation of the early-region-2 transcription-factor-1-retinoblastoma-protein (E2F-1-RB) transrepressor and release of the retinoblastoma protein from nuclear complexes containing cyclin A is induced by interferon alpha in U937V cells but not in interferon-alpha-resistant U937VR cells.
    Kirch HC; Putzer B; Brockmann D; Esche H; Kloke O
    Eur J Biochem; 1997 Jun; 246(3):736-44. PubMed ID: 9219533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites.
    Sellers WR; Rodgers JW; Kaelin WG
    Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11544-8. PubMed ID: 8524800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual mechanisms for the inhibition of E2F binding to RB by cyclin-dependent kinase-mediated RB phosphorylation.
    Knudsen ES; Wang JY
    Mol Cell Biol; 1997 Oct; 17(10):5771-83. PubMed ID: 9315635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of retinoblastoma protein function by specific Cdk phosphorylation sites.
    Knudsen ES; Wang JY
    J Biol Chem; 1996 Apr; 271(14):8313-20. PubMed ID: 8626527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E2F transcription factor is a target for the RB protein and the cyclin A protein.
    Nevins JR; Chellappan SP; Mudryj M; Hiebert S; Devoto S; Horowitz J; Hunter T; Pines J
    Cold Spring Harb Symp Quant Biol; 1991; 56():157-62. PubMed ID: 1840249
    [No Abstract]   [Full Text] [Related]  

  • 8. p120-v-Abl expression overcomes TGF-beta1 negative regulation of c-myc transcription but not cell growth.
    Birchenall-Roberts MC; Kim SJ; Bertolette DC; Turley JM; Fu T; Bang OS; Kasper JJ; Yoo YD; Ruscetti FW
    Oncogene; 1996 Oct; 13(7):1499-509. PubMed ID: 8875988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor beta through E2F binding sites.
    Li JM; Hu PP; Shen X; Yu Y; Wang XF
    Proc Natl Acad Sci U S A; 1997 May; 94(10):4948-53. PubMed ID: 9144170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1.
    Harbour JW; Luo RX; Dei Santi A; Postigo AA; Dean DC
    Cell; 1999 Sep; 98(6):859-69. PubMed ID: 10499802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation.
    Kiess M; Gill RM; Hamel PA
    Cell Growth Differ; 1995 Oct; 6(10):1287-98. PubMed ID: 8845306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of distinct roles for separate E1A domains in disruption of E2F complexes.
    Ikeda MA; Nevins JR
    Mol Cell Biol; 1993 Nov; 13(11):7029-35. PubMed ID: 8413292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner.
    Shirodkar S; Ewen M; DeCaprio JA; Morgan J; Livingston DM; Chittenden T
    Cell; 1992 Jan; 68(1):157-66. PubMed ID: 1531040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions.
    Oswald F; Lovec H; Möröy T; Lipp M
    Oncogene; 1994 Jul; 9(7):2029-36. PubMed ID: 8208548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of Rb and E2F by signal transduction cascades: divergent effects of JNK1 and p38 kinases.
    Wang S; Nath N; Minden A; Chellappan S
    EMBO J; 1999 Mar; 18(6):1559-70. PubMed ID: 10075927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of irreversible growth arrest in myogenic differentiation requires the RB LXCXE-binding function.
    Chen TT; Wang JY
    Mol Cell Biol; 2000 Aug; 20(15):5571-80. PubMed ID: 10891495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of a retinoblastoma-protein-dependent pathway by sphingosine.
    Dbaibo GS; Wolff RA; Obeid LM; Hannun YA
    Biochem J; 1995 Sep; 310 ( Pt 2)(Pt 2):453-9. PubMed ID: 7654183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for phosphorylation-induced E2F release.
    Rubin SM; Gall AL; Zheng N; Pavletich NP
    Cell; 2005 Dec; 123(6):1093-106. PubMed ID: 16360038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential specificity for binding of retinoblastoma binding protein 2 to RB, p107, and TATA-binding protein.
    Kim YW; Otterson GA; Kratzke RA; Coxon AB; Kaye FJ
    Mol Cell Biol; 1994 Nov; 14(11):7256-64. PubMed ID: 7935440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retinoblastoma-binding protein that affects cell-cycle control and confers transforming ability.
    Woitach JT; Zhang M; Niu CH; Thorgeirsson SS
    Nat Genet; 1998 Aug; 19(4):371-4. PubMed ID: 9697699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.